In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …

Half of patients with heart failure (HF) have a preserved left ventricular ejection fraction
(HFpEF). Morbidity and mortality in HFpEF are similar to values observed in patients with HF …

Background—Heart failure with preserved ejection fraction (EF) is a common syndrome, but
trends in treatments and outcomes are lacking. Methods and Results—We analyzed data …

Background: In nonrandomized, open-label studies, a transcatheter interatrial shunt device
(IASD, Corvia Medical) was associated with lower pulmonary capillary wedge pressure …

Background—When advanced, heart failure with preserved ejection fraction (HFpEF) is
readily apparent. However, diagnosis of earlier disease may be challenging because …

Heart failure with preserved ejection fraction (HFPEF) is increasingly recognized as a major
public health problem worldwide. Significant advances have been made in our …

Objectives: This study sought to determine the prognostic value of B-type natriuretic peptide
(BNP) in patients with heart failure with preserved ejection fraction (HFPEF), in comparison …

Background—The prevalence of heart failure with preserved ejection fraction is increasing.
The prognosis worsens with pulmonary hypertension and right ventricular (RV) failure …

Aims The aim of this study was to evaluate whether biomarkers reflecting pathophysiological
pathways are different between heart failure with preserved (HFpEF) and reduced ejection …

B-type natriuretic peptide (BNP) is used widely to exclude heart failure (HF) in patients with
dyspnea. However, most studies of BNP have focused on diagnosing HF with reduced …